COVID-19: New adaptation for IVF laboratory protocols

JBRA Assist Reprod. 2020 Jul 14;24(3):358-361. doi: 10.5935/1518-0557.20200054.


Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) widely known as COVID-19 was first reported in late December 2019, in China. Since then this novel coronavirus has spread throughout the world. Our return to normal life will not take long, for we are in a phase where the COVID-19 curve is stabilizing. ART services must return to operation, since infertility is also a disease and treatment has to start. Before resuming ART treatments, it is very important to consider local and national regulations. Change is mandatory, to set us back to successful ART treatment without compromising on quality, and to minimize the spread of COVID-19 among staff and patients; and for this we need to take measured and vigilant steps.

Keywords: COVID-19; IVF laboratory; new adaptations.

Publication types

  • Review

MeSH terms

  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections* / prevention & control
  • Coronavirus Infections* / transmission
  • Fertilization in Vitro*
  • Humans
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / prevention & control
  • Pneumonia, Viral* / transmission
  • Reproductive Techniques, Assisted
  • SARS-CoV-2